Beam Therapeutics Inc. Equity Repurchase (Preffered, Net)

Equity Repurchase (Preffered, Net) of BEAM for past 10 years: annual, quarterly and twelve month trailing (TTM) including Equity Repurchase (Preffered, Net) growth rates and interactive chart.


Highlights and Quick Summary

  • Equity Repurchase (Preffered, Net) for the quarter ending December 31, 2019 was $0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Equity Repurchase (Preffered, Net) decreased by -100.0%
  • Annual Equity Repurchase (Preffered, Net) for 2019 was $37.9 Million (a -78.91% decrease from previous year)
  • Twelve month Equity Repurchase (Preffered, Net) ending December 31, 2019 was $37.9 Million
Trailing Equity Repurchase (Preffered, Net) for the last four month:
31 Dec '19
$37.9 Million
Visit stockrow.com/BEAM for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Equity Repurchase (Preffered, Net) of Beam Therapeutics Inc.

Most recent Equity Repurchase (Preffered, Net)of BEAM including historical data for past 10 years.

Interactive Chart of Equity Repurchase (Preffered, Net) of Beam Therapeutics Inc.

Beam Therapeutics Inc. Equity Repurchase (Preffered, Net) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2019 $0.0 $0.0 $0.0 $37.9 $37.9
2018 $179.72

Business Profile of Beam Therapeutics Inc.

Sector: Healthcare
Industry: Biotechnology